Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_assertion type Assertion NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_head.
- NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_assertion description "[Because two of the seven human myeloma cell lines which were established at Kawasaki Medical School, Okayama, Japan, KMS-11 and KMS-18, have been proven to possess t(4;14)(q16.3;q32.3), we studied the expression levels of the FGFR3 gene in these seven cell lines and 13 primary myeloma specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_provenance.
- NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_assertion evidence source_evidence_literature NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_provenance.
- NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_assertion SIO_000772 10568829 NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_provenance.
- NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_assertion wasDerivedFrom befree-20140225 NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_provenance.
- NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_assertion wasGeneratedBy ECO_0000203 NP926153.RA0hlZ7K2RTEOSrDjbjuxoe52Wu-Rd_e3mRU9kyKiUSKw130_provenance.